(2016) Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis. Clinical immunology (Orlando, Fla.). pp. 98-106. ISSN 1521-7035